Effectiveness of Group Cognitive Behavioral Therapy and the Role of Cognitive Ability in Adult Attention-Deficit/Hyperactivity Disorder
Article information
Abstract
Objective
Attention-deficit/hyperactivity disorder (ADHD) frequently persists into adulthood and leads to significant impairment across multiple domains. Cognitive behavioral therapy (CBT) has been proposed as a promising adjunctive treatment. We aimed to evaluate the effectiveness of a structured group-based CBT program for adults with ADHD and examine whether cognitive ability and treatment adherence moderate treatment response.
Methods
A retrospective analysis was conducted on 24 adults who completed a 10-session group CBT program. ADHD symptoms were assessed pre and postintervention using the Adult ADHD Self-Report Scale (ASRS) and Korean Adult ADHD Rating Scale (K-AARS). Subgroup analyses were performed based on full-scale intelligence quotient (FSIQ), session attendance, and presence of comorbid depression.
Results
A significant improvement in symptoms was observed across most ASRS and K-AARS domains. Functional impairment, as measured using the K-AARS impairment subscale, also improved significantly. Participants with an average FSIQ (90–109) showed the most consistent improvements, whereas those with below-average and high FSIQ also benefited to varying degrees. Higher attendance rates were associated with greater reduction in symptoms. The presence of comorbid depression did not significantly affect the treatment outcomes.
Conclusion
Group-based CBT is an effective adjunct intervention for managing adult ADHD symptoms. Notably, the intervention led to significant improvements in functional impairment, highlighting its potential to enhance daily functioning in adults with ADHD. Tailoring interventions based on cognitive profiles and emphasizing treatment adherence may enhance therapeutic outcomes. Future studies should employ larger sample sizes, randomized controlled designs, and longitudinal follow-up assessments to validate and extend these findings.
INTRODUCTION
Attention-deficit/hyperactivity disorder (ADHD) is characterized by persistent patterns of inattention, hyperactivity, and impulsivity, typically manifesting during childhood and often persisting into adulthood. Globally, the prevalence of childhood ADHD is estimated at approximately 5%, with rates similar to those reported in South Korea [1,2]. ADHD symptoms frequently continue into adulthood, with approximately 60% of individuals diagnosed as children still experiencing symptoms similar to adults [3].
Many studies have suggested that impulsivity and hyperactivity symptoms in individuals with ADHD tend to diminish with age, whereas inattention symptoms are relatively persistent [4]. One of the hallmark features of adult ADHD. Deficits in attention make it difficult for individuals with ADHD to sustain their focus on tasks, and they are more easily distracted in situations requiring concentration, making it difficult to complete everyday tasks [5].
These symptoms significantly impair social, academic, and occupational functioning during adulthood. Academic underachievement is a major challenge faced by adults with ADHD. Adults with ADHD are less likely to pursue higher education compared to the general population, with attention-related ADHD symptoms contributing to lower performance in reading, spelling, and mathematics [6]. Secondly, workplace challenges are common, with difficulties in deadlines, maintaining efficiency, and adhering to professional standards. Frequent mistakes and difficulties in interpersonal relationships further compound these issues [7]. Finally, ADHD symptoms often interfere with social relationships, romantic partnerships, and marital stability, thus requiring greater effort to maintain a healthy family life.
Adults with ADHD also struggle with time management and organization in their daily lives. They often focus excessively on the present, making it difficult to plan and achieve long-term goals through sustained effort [5]. Given that ADHD frequently persists into adulthood, long-term treatment for adult ADHD is essential. Effective management of adult ADHD has been shown to positively impact academic achievement, occupational success, interpersonal relationships, antisocial behavior, and mood symptoms such as depression and anxiety [8]. While pharmacotherapy is effective in rapidly improving core symptoms of inattention and hyperactivity, it often fails to address every challenge faced by individuals with ADHD [9-11]. Many adults with ADHD continue to experience residual symptoms despite medication, highlighting the need for complementary interventions such as cognitive behavioral therapy (CBT) [12].
CBT plays a crucial role in managing adult ADHD by addressing deficits in executive functioning, such as difficulties with inattention and organization [12]. It positively impacts the ability to maintain structured routines and achieve personal goals while also improving impulse control, organized living, and self-management. Through CBT, individuals learn to observe and analyze their own behavior, thereby reducing impulsive reactions. Additionally, by acquiring skills in planning schedules and setting priorities, individuals can enhance their daily efficiency. CBT aims to identify and modify negative behavioral patterns, helping individuals develop positive behaviors and healthier stress-coping strategies. It enhances self-efficacy by enabling individuals to achieve their goals in daily life systematically, thereby promoting self-confidence and independence [11,13-15].
Group-based CBT involves multiple participants in a collective setting sharing their experiences and addressing core ADHD symptoms using CBT techniques. This approach allows participants to exchange experiences, build empathy for the challenges they face, and gain confidence through mutual support from the group [15]. Despite the benefits of group-based CBT, there are relatively few randomized controlled trials based on well-structured CBT programs. Therefore, we aimed to empirically evaluate the effectiveness of group-based CBT in managing symptoms and improving function in adults with ADHD, thereby providing foundational data to inform long-term treatment strategies for adult ADHD.
METHODS
Participants
This was a retrospective chart review of adult patients with ADHD who participated in a group-based CBT program conducted at a single university hospital in Seoul between June 2021 and August 2024. The inclusion criteria were as follows: 1) adults aged ≥18 years, 2) a confirmed diagnosis of ADHD and ongoing psychiatric treatment, and 3) completion of at least 50% of the 10 weekly CBT sessions and post-treatment assessment. No additional exclusion criteria were applied, and participants were not excluded based on changes in ADHD medication type or dosage during the program. The CBT program was delivered over a 10-week period per group, and six group cohorts were conducted during the study period. Although the participants were referred from three different hospitals, all CBT sessions and data collection were conducted at a single institution.
A total of 33 patients participated in the CBT program during the study period. Of these, two were excluded because of the development of psychotic symptoms during the program, one died, and six did not complete the required minimum number of sessions. Therefore, 24 patients were included in the final analysis. This study was approved by the Institutional Review Board of the Kyung Hee University Hospital (IRB No. KHUH 2024-10-021).
Group-based CBT
The group-based CBT program was developed based on established protocols used by researchers such as Hesslinger et al. [16], Ramsay and Rostain [17], Safren et al. [18], and Solanto and Scheres [19], as well as treatment manuals previously utilized by the authors. The program consisted of 10 weekly sessions, each lasting 120 minutes. When designing the program, sessions were scheduled once weekly. Based on the authors’ previous clinical experience, maintaining the total duration within 3 months resulted in higher attendance and completion rates. Therefore, the program was structured into 10 sessions. The primary objectives of the program were to teach practical coping skills, reinforce and shape positive behaviors, and replace maladaptive cognition with more adaptive patterns through behavioral and cognitive-behavioral techniques. The program also targeted common executive functioning deficits in adults with ADHD such as difficulties in time management, organization, and planning.
The structure and content of each session are shown in Supplementary Table 1. Each session included topic-specific psychoeducation, in-session modeling and demonstration of metacognitive strategies, identification and modification of barriers to successful implementation (e.g., cognitive distortions), and homework assignments to reinforce key concepts.
Each group was led by a qualified clinical psychologist as the primary therapist, with support from a clinical psychology trainee who served as an assistant therapist. Although the therapists were not identical across groups, all sessions were conducted under the supervision of a licensed clinical psychologist.
Measures
All outcome measures were administered at two timepoints: immediately before the first CBT session and immediately after the final session.
Adult ADHD Self-Report Scale
The Adult ADHD Self-Report Scale (ASRS) [20,21] is a self-report scale based on the World Health Organization Composite International Diagnostic Interview. It consists of 18 questions designed to assess current manifestations of ADHD symptoms. The scale is intended for use with people aged ≥18 years and takes approximately 5 minutes to complete. Respondents used a 5-point Likert scale to indicate the frequency of ADHD symptoms over the past 6 months, with response options ranging from 0 (never) to 4 (very often), with total scores ranging 0–72. The ASRS is divided into following two parts: Part A contains six items and serves as a screening tool, whereas Part B includes 12 additional questions aligned with the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for ADHD. The Korean version of the ASRS was translated and standardized by Kim et al. [21].
Korean Adult ADHD Rating Scale
The Korean Adult ADHD Rating Scale (K-AARS) [22,23] is a self-reported scale consisting of 73 questions. It was developed in 2015 by the Korean Academy of Child and Adolescent Psychiatry after reviewing five established ADHD assessment tools: the Conners Adult ADHD Rating Scale, Brown Attention-Deficit Disorder Scale, Wender Utah Rating Scale, Barkley’s Adult ADHD Rating Scale-IV, and the ASRS. Responses were recorded on a 5-point Likert scale: never (1), rarely (2), sometimes (3), often (4), and always (5). Participants evaluated how frequently they had experienced each symptom in the past 6 months. However, because this measure assesses symptoms over a 6 months period, the post-assessment results would have included symptoms from before the group CBT program. To address this, we modified the post-assessment instructions to ask participants to rate their symptoms over the most recent 2 months period. The K-AARS is divided into eight subscales and is organized into three parts: 1) six clinical subscales containing 55 questions, 2) an impairment subscale with six questions, and 3) a driving behavior subscale with 12 questions. The six clinical subscales are inattention, hyperactivity, impulsivity, antisocial personality/conduct behavior/oppositional defiant behavior (APD/CD/ODD), emotional dysregulation, and disorganization. Higher scores on the six clinical and impairment subscales indicated greater symptom severity. Impairment subscale was specifically designed with items to measure the severity in accordance with the DSM-5 diagnostic criteria for adults with ADHD. A clinical subscale score of 132 or higher out of 275 indicated the need for further evaluation to confirm the ADHD diagnosis. In the present study the driving behavior subscale was excluded from the analysis because none of the participants reported driving.
Statistical analyses
All statistical analyses were performed using SPSS version 29 (IBM Corp.). Descriptive statistics were used to summarize the demographic and clinical characteristics of participants. To evaluate the changes in ADHD symptoms following the CBT group intervention, paired t-tests were conducted to compare the pre- and post-treatment scores on the ASRS and K-AARS. Additionally, linear mixed model analyses were employed to assess whether treatment outcomes differed according to baseline cognitive ability (full-scale intelligence quotient, FSIQ) and session attendance.
RESULTS
A total of 24 participants (10 males and 14 females) completed a group-based CBT program for adult ADHD. The mean age was 27.71±5.92 years and the average age at diagnosis was 24.86±6.89 years. Educational attainment varied, with most participants completing a college-level education (66.7%). Employment status was equally distributed among students (33.3%) and employed individuals (33.3%); 25.0% were unemployed. Most participants were single (66.7%). Nine participants (37.5%) had comorbid mood disorders, including eight with depression and one with bipolar disorder. Most (83.3%) patients received pharmacotherapy. The average FSIQ was 108.14±16.71 (Table 1).
Following the intervention, ADHD symptoms significantly improved, as measured by both the ASRS and K-AARS (Table 2 and Figure 1). The ASRS showed significant reductions across all subdomains, including a decrease in total score from 39.7±8.1 to 28.7±11.6, with both Parts A and B also significantly improved (p<0.001). On the K-AARS, notable improvements were found across all subscales except for hyperactivity. Functional impairment also significantly improved (K-AARS impairment subscale: mean reduction 3.6, p<0.001), reflecting positive changes in daily functioning. To confirm the robustness of these findings, a linear mixed-effects model controlling for demographic and clinical covariates was used, which showed consistent and significant symptom reduction in the ASRS and K-AARS (Table 3).
Comparison of mean scores before and after the CBT intervention across major ADHD symptom domains. CBT, cognitive behavioral therapy; ADHD, attention-deficit/hyperactivity disorder; ASRS, Adult ADHD Self-Report Scale; K-AARS, Korean Adult ADHD Rating Scale; APD/CD/ODD, antisocial personality disorder/conduct disorder/oppositional defiant disorder.
To explore the role of cognitive ability, participants were stratified into three FSIQ groups: high (≥110), average (90–109), and below average (<90). Significant reductions were observed in ASRS and K-AARS scores in all groups, although the magnitude and consistency varied. The average-IQ group showed the broadest improvements across the subscales, whereas the below-average group showed fewer significant changes (Table 4).
To evaluate the association between treatment adherence and symptom improvement, participants were categorized into three groups based on session attendance: 100% attendance (n=14), 70%–99% attendance (n=8), and <70% attendance (n=2). Both the 100% and 70%–99% attendance groups demonstrated significant improvements across most ASRS and K-AARS domains. In contrast, the <70% group showed minimal changes, with only the total ASRS scores reaching significance (p=0.049) (Table 5).
The impact of comorbid depression was evaluated by comparing outcomes between participants with (n=8) and without (n=15) depression. Both groups showed significant improvements in the ASRS and K-AARS scores, with similar patterns across subscales, except for hyperactivity (Table 6).
Stratified analyses revealed consistent treatment effects across subgroups. Greater reductions in ASRS scores were observed among participants with lower FSIQ scores, whereas the largest K-AARS improvements were observed in the average-IQ group. Participants with full attendance and comorbid depression also showed greater reductions than their counterparts. The detailed results of the subgroup analyses are presented in Supplementary Table 2.
DISCUSSION
This study investigated the effectiveness of a 10-session group-based CBT program for managing the symptoms of adult ADHD, as measured by the ASRS and K-AARS. The results demonstrated significant improvements across multiple symptom domains on both scales. Importantly, treatment outcomes varied depending on the participants’ cognitive abilities and attendance rates, suggesting that these factors may influence the therapeutic response.
The intervention led to meaningful improvements in inattention, disorganization, and overall functional impairment as measured by the K-AARS impairment index. These symptom domains were strongly associated with academic and occupational difficulties. Notably, the significant improvement in functional impairment highlights the intervention’s real-world effectiveness, as impairment is a core diagnostic criterion for adult ADHD and a primary target for treatment. These findings align with previous meta-analytic evidence indicating that CBT can significantly reduce core ADHD symptoms in adults, particularly inattention and disorganization, which are among the most impairing aspects of the disorder [24,25]. Improvements in these areas are likely to enhance daily functioning, underscoring the clinical value of targeting executive dysfunction in CBT.
Although not included in the DSM-5 diagnostic criteria for ADHD, emotional dysregulation showed significant improvement. Given the strong association with adverse functional outcomes and comorbid emotional disorders, this finding is clinically relevant. Previous research has emphasized the importance of addressing emotional symptoms in ADHD treatment to improve the overall quality of life [26]. These findings suggest that structured CBT may simultaneously address both core symptoms and associated emotional difficulties, extending its benefits beyond symptom reduction to include improved emotional self-regulation [25].
Interestingly, hyperactivity did not improve significantly, which may reflect a developmental trajectory. Previous longitudinal studies have shown that hyperactive behaviors tend to decline or become internalized with age, whereas inattention and executive dysfunction remain persistent and impaired. These findings highlight the importance of focusing treatment efforts on the domains of inattention, disorganization, and emotional dysregulation in order to optimize functional outcomes in adults with ADHD.
Participants with an average IQ (90–109) demonstrated the most consistent and robust improvements. In contrast, those with high IQ (≥110) showed more selective gains, particularly in inattention and APD/CD/ODD, while emotional dysregulation, impulsivity, and disorganization did not significantly improve. This pattern suggests that cognitive ability may moderate treatment outcomes. While higher intelligence is often assumed to enhance responsiveness to CBT, the empirical findings remain mixed. For example, Haaga et al. [27] found no linear relationship between IQ and CBT outcomes in patients with mood and anxiety disorders, indicating that higher intelligence alone does not consistently predict better therapeutic outcomes. Similarly, Mostert et al. [28] reported that adults with ADHD and IQ ≥115 showed fewer executive function deficits, potentially due to compensatory strategies, which may reduce the observable benefit of structured CBT. Participants with below-average IQ (<90) also showed meaningful improvements, although the effects were less pronounced than in the other groups. Due to the small sample size, these findings should be interpreted with caution. Nevertheless, these results are consistent with previous research suggesting that individuals with lower cognitive ability may experience reduced benefits from CBT, likely due to the cognitive demands involved [29]. Overall, these results highlighting the importance of considering cognitive profiles when implementing CBT for adult ADHD. While the intervention appears to be broadly beneficial, tailoring the approach based on cognitive capacity may optimize treatment outcomes.
Treatment adherence, as reflected by session attendance, emerged as a critical factor influencing the therapeutic outcomes in this study. Consistent with prior research showing a dose-response relationship between CBT session exposure and symptom improvement in adults with ADHD, our findings demonstrated that the degree of improvement varied by attendance level [19,30,31]. Participants with full attendance exhibited broader and more consistent symptom reductions, particularly in executive functioning domains such as disorganization and emotional dysregulation. In contrast, even partial absences (e.g., missing one or two sessions) were associated with diminished gains in these domains. These results underscore the cumulative value of attending all sessions in a sequentially designed CBT program, in which later modules build upon earlier skills. As highlighted in previous studies, the acquisition and generalization of CBT techniques require repeated rehearsal and sustained exposure to core strategies [14]. High session attendance may therefore reflect treatment engagement and sufficient exposure for skills to consolidate and translate into real-world improvements. These findings underscore the importance of maintaining treatment adherence throughout the intervention. Strategies such as motivational support, flexible scheduling, and booster sessions may benefit adults with ADHD experiencing organizational difficulties. Moreover, as noted by Skliarova et al. [32], session attendance may serve not only as a proxy for treatment engagement, but also as an indicator of how participants perceive the relevance and utility of the intervention.
Given the prognostic importance of psychiatric comorbidities in adults with ADHD, we conducted an additional analysis to examine whether comorbid depression moderated treatment outcomes. The results showed that CBT was equally effective regardless of the depression status, supporting prior evidence that comorbid depression does not diminish the efficacy of CBT in reducing ADHD symptoms. Previous studies have shown that CBT remains effective even when controlling for depression severity [11]. Furthermore, high session attendance has been associated with greater symptom improvement irrespective of comorbid depression [24], whereas severe depression has been linked to poorer outcomes, possibly due to reduced adherence [33]. The current findings may partially reflect sample characteristics and selection effects, as participants with stable depressive symptoms were more likely to enroll and complete the program. Those with severe or untreated depression may have been excluded or may have dropped out early. Although depression severity was not formally assessed, the high session completion rate suggests that most participants were in a clinically stable condition, which may have contributed to the consistent treatment responses observed across the groups.
Despite the significant contributions of this study, several limitations should be considered. First, it used a retrospective chart review design. While this design allows for real-world assessment of a clinical program, it inherently limits control over confounding variables and introduces potential selection bias. These limitations should be considered when interpreting the findings. Second, the study did not include a control group, which limited the ability to compare and verify treatment effects. However, the primary objective of this study was to evaluate the pre- and post-treatment changes in ADHD symptoms following group CBT, and clinically meaningful results were confirmed using this approach. Third, changes in ADHD symptom were assessed solely using self-report measures (ASRS and K-AARS), which may have been subject to response bias. However, while previous studies have assessed impairment in ADHD symptoms using measures such as CGI-S34 or adult attention-deficit/hyperactivity disorder quality of life scale35 the significance of this study lies in the fact that it is the first to evaluate the severity of impairment based on DSM-5 diagnostic criteria using the impairment subscale of K-AARS. Future studies should include clinician-rated or multi-informant assessments to improve objectivity. Fourth, although the relatively small sample size affected the generalizability of the findings, this exploratory study provides valuable foundational data. Future studies should adopt randomized controlled designs with larger and more diverse samples to validate and extend these results. Lastly, although comorbid mood disorders such as depression and bipolar disorder were identified, the severity of depressive symptoms was not assessed; however, the participants’ ability to attend and complete the majority of CBT sessions suggests that their depressive symptoms were likely well-managed and not in an acute or severe state.
Supplementary Materials
The Supplement is available with this article at https://doi.org/10.30773/pi.2025.0184.
10-session CBT program for adults with ADHD: a roadmap to clarity, action, and growth
Stratified analysis of CBT outcomes by baseline cognitive ability (FSIQ), attendance rate, and comorbid depression
Notes
Availability of Data and Material
The datasets generated or analyzed during the study are available from the corresponding author upon reasonable request.
Conflicts of Interest
The authors have no potential conflicts of interest to disclose.
Author Contributions
Conceptualization: Miae Oh, Seong Ae Lee, Geon Ho Bahn. Data curation: Miae Oh, Seong Ae Lee, Chae-Bin Kim. Formal analysis: Nan-He Yoon, Seong Ae Lee. Funding acquisition: Miae Oh. Investigation: Chae-Bin Kim, Ah Rah Lee, Seong Ae Lee. Methodology: Miae Oh, Nan-He Yoon, Seong Ae Lee. Software: Nan-He Yoon, Seong Ae Lee, Chae-Bin Kim. Validation: Nan-He Yoon, Ah Rah Lee, Seong Ae Lee. Writing—original draft: Miae Oh, Seong Ae Lee. Writing—review & editing: Miae Oh, Seong Ae Lee, Geon Ho Bahn.
Funding Statement
This work was supported by the Technology Innovation Program (No. 20023378, The human microbiome, which modulates serotonin and intestinal Th17 cells, ameliorates the severity of autism spectrum disorder) funded By the Ministry of Trade, Industry & Energy (MOTIE, Korea) and the Brain Research Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. RS-2024-00439474).
Acknowledgments
We are grateful to Professors Moon-Soo Lee and Soo-Young Bang for their support in patient referral, which made this study possible.
